Floatz logo

Single Dose Mpcs

Lumbar Disk Degenerative Disorder

Mesoblast, Ltd.Cell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Lumbar Disk Degenerative Disorder cohort.

Asset / SponsorPhaseRating
NEPENTHE
Brigham and Women's Hospital
Phase 4BB
Oxycodone
Brigham and Women's Hospital
Phase 4BB
Pentoxifylline
St Joseph University, Beirut, Lebanon
Phase 4BB
IBUPROFEN
St Joseph University, Beirut, Lebanon
Phase 4BB
AUTOLOGOUS CONDITIONED PLASMA
Allmed Medical Center
Phase 2BB

View all 15 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →